

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of ER to Golgi vesicle-mediated transport (GO:0060628) | 9.98059228 |
| 2 | response to pheromone (GO:0019236) | 8.72739699 |
| 3 | high-density lipoprotein particle remodeling (GO:0034375) | 7.71644720 |
| 4 | * leukotriene biosynthetic process (GO:0019370) | 7.06484462 |
| 5 | interferon-gamma secretion (GO:0072643) | 6.92393167 |
| 6 | phosphatidylethanolamine metabolic process (GO:0046337) | 6.77337894 |
| 7 | reverse cholesterol transport (GO:0043691) | 6.60648020 |
| 8 | * glutathione biosynthetic process (GO:0006750) | 6.01067988 |
| 9 | cobalamin metabolic process (GO:0009235) | 5.89490197 |
| 10 | phospholipid efflux (GO:0033700) | 5.80372808 |
| 11 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.79044202 |
| 12 | regulation of triglyceride catabolic process (GO:0010896) | 5.69750282 |
| 13 | * nonribosomal peptide biosynthetic process (GO:0019184) | 5.60621749 |
| 14 | alanine transport (GO:0032328) | 5.20503724 |
| 15 | protein-lipid complex remodeling (GO:0034368) | 5.15117696 |
| 16 | macromolecular complex remodeling (GO:0034367) | 5.15117696 |
| 17 | plasma lipoprotein particle remodeling (GO:0034369) | 5.15117696 |
| 18 | ribosome assembly (GO:0042255) | 5.13538470 |
| 19 | proline transport (GO:0015824) | 4.92246656 |
| 20 | transcription from mitochondrial promoter (GO:0006390) | 4.89517470 |
| 21 | phosphatidylethanolamine biosynthetic process (GO:0006646) | 4.88869374 |
| 22 | regulation of cholesterol esterification (GO:0010872) | 4.86230185 |
| 23 | * leukotriene metabolic process (GO:0006691) | 4.81065999 |
| 24 | polyol transport (GO:0015791) | 4.76469108 |
| 25 | negative regulation of interleukin-2 production (GO:0032703) | 4.63737554 |
| 26 | * peptide biosynthetic process (GO:0043043) | 4.55309080 |
| 27 | * icosanoid biosynthetic process (GO:0046456) | 4.46936592 |
| 28 | * fatty acid derivative biosynthetic process (GO:1901570) | 4.46936592 |
| 29 | glycerophospholipid catabolic process (GO:0046475) | 4.24966954 |
| 30 | negative regulation of viral release from host cell (GO:1902187) | 4.23384327 |
| 31 | thyroid hormone generation (GO:0006590) | 4.16368716 |
| 32 | cysteine metabolic process (GO:0006534) | 4.13370533 |
| 33 | peptide catabolic process (GO:0043171) | 4.08348380 |
| 34 | lipoprotein transport (GO:0042953) | 4.01644808 |
| 35 | auditory behavior (GO:0031223) | 4.00637782 |
| 36 | protein K11-linked deubiquitination (GO:0035871) | 3.99487753 |
| 37 | negative regulation of viral transcription (GO:0032897) | 3.89908753 |
| 38 | * glutathione metabolic process (GO:0006749) | 3.83758568 |
| 39 | artery development (GO:0060840) | 3.83275087 |
| 40 | gastrulation with mouth forming second (GO:0001702) | 3.74683089 |
| 41 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.73981323 |
| 42 | cochlea development (GO:0090102) | 3.70198129 |
| 43 | plasma lipoprotein particle organization (GO:0071827) | 3.69952545 |
| 44 | sulfur amino acid biosynthetic process (GO:0000097) | 3.69334049 |
| 45 | cholesterol efflux (GO:0033344) | 3.67848116 |
| 46 | myotube differentiation (GO:0014902) | 3.63451435 |
| 47 | plasma lipoprotein particle assembly (GO:0034377) | 3.59281965 |
| 48 | * unsaturated fatty acid biosynthetic process (GO:0006636) | 3.58632510 |
| 49 | protein-lipid complex subunit organization (GO:0071825) | 3.52388394 |
| 50 | regulation of viral release from host cell (GO:1902186) | 3.51257924 |
| 51 | cell migration in hindbrain (GO:0021535) | 3.45842633 |
| 52 | ectoderm development (GO:0007398) | 3.39707680 |
| 53 | thyroid hormone metabolic process (GO:0042403) | 3.36884569 |
| 54 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.36851465 |
| 55 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.36851465 |
| 56 | embryonic foregut morphogenesis (GO:0048617) | 3.30946705 |
| 57 | protein-lipid complex assembly (GO:0065005) | 3.28266641 |
| 58 | protein K63-linked ubiquitination (GO:0070534) | 3.25616343 |
| 59 | phosphatidylcholine biosynthetic process (GO:0006656) | 3.23829236 |
| 60 | negative regulation of cytokine secretion (GO:0050710) | 3.23324794 |
| 61 | plasma lipoprotein particle clearance (GO:0034381) | 3.23103554 |
| 62 | icosanoid secretion (GO:0032309) | 3.18569613 |
| 63 | arachidonic acid secretion (GO:0050482) | 3.18569613 |
| 64 | positive regulation of protein import into nucleus, translocation (GO:0033160) | 3.18467407 |
| 65 | estrogen biosynthetic process (GO:0006703) | 3.17691388 |
| 66 | regulation of triglyceride metabolic process (GO:0090207) | 3.17645083 |
| 67 | actin nucleation (GO:0045010) | 3.13808643 |
| 68 | negative regulation of lipase activity (GO:0060192) | 3.13334468 |
| 69 | homocysteine metabolic process (GO:0050667) | 3.06132793 |
| 70 | negative regulation of cholesterol transport (GO:0032375) | 3.05073732 |
| 71 | negative regulation of sterol transport (GO:0032372) | 3.05073732 |
| 72 | lymphangiogenesis (GO:0001946) | 3.04607070 |
| 73 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.03223816 |
| 74 | negative regulation of astrocyte differentiation (GO:0048712) | 3.02668211 |
| 75 | one-carbon compound transport (GO:0019755) | 3.01744866 |
| 76 | cilium or flagellum-dependent cell motility (GO:0001539) | 2.99411825 |
| 77 | startle response (GO:0001964) | 2.97142201 |
| 78 | oligosaccharide catabolic process (GO:0009313) | 2.96980850 |
| 79 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 2.96431237 |
| 80 | protein K6-linked ubiquitination (GO:0085020) | 2.95613252 |
| 81 | protein targeting to Golgi (GO:0000042) | 2.91599061 |
| 82 | methionine biosynthetic process (GO:0009086) | 2.90873440 |
| 83 | lipoprotein metabolic process (GO:0042157) | 2.88960122 |
| 84 | digestion (GO:0007586) | 2.87592275 |
| 85 | positive regulation of Rho protein signal transduction (GO:0035025) | 2.87583039 |
| 86 | fatty acid derivative transport (GO:1901571) | 2.86950411 |
| 87 | icosanoid transport (GO:0071715) | 2.86950411 |
| 88 | negative regulation of lipid catabolic process (GO:0050995) | 2.82465816 |
| 89 | establishment or maintenance of monopolar cell polarity (GO:0061339) | 2.78469076 |
| 90 | establishment of monopolar cell polarity (GO:0061162) | 2.78469076 |
| 91 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 2.75621046 |
| 92 | establishment of protein localization to Golgi (GO:0072600) | 2.71538622 |
| 93 | * icosanoid metabolic process (GO:0006690) | 2.70926626 |
| 94 | * fatty acid derivative metabolic process (GO:1901568) | 2.70926626 |
| 95 | maintenance of gastrointestinal epithelium (GO:0030277) | 2.70319716 |
| 96 | organ growth (GO:0035265) | 2.68450726 |
| 97 | glycerolipid catabolic process (GO:0046503) | 2.67350585 |
| 98 | phosphatidylcholine metabolic process (GO:0046470) | 2.64891696 |
| 99 | cellular response to hepatocyte growth factor stimulus (GO:0035729) | 2.63795600 |
| 100 | response to hepatocyte growth factor (GO:0035728) | 2.63795600 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | GATA1_22025678_ChIP-Seq_K562_Human | 6.81829178 |
| 2 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 4.86691965 |
| 3 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 4.73807073 |
| 4 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 3.91078829 |
| 5 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.60453304 |
| 6 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.57644705 |
| 7 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.14755815 |
| 8 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.02670061 |
| 9 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.83040453 |
| 10 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.78605602 |
| 11 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.65222934 |
| 12 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.64931735 |
| 13 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.61116848 |
| 14 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.56284622 |
| 15 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.55780084 |
| 16 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.52766487 |
| 17 | RAC3_21632823_ChIP-Seq_H3396_Human | 1.49065259 |
| 18 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.47118343 |
| 19 | P68_20966046_ChIP-Seq_HELA_Human | 1.41747703 |
| 20 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.39671165 |
| 21 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.38992664 |
| 22 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.38865829 |
| 23 | P300_27268052_Chip-Seq_Bcells_Human | 1.37748217 |
| 24 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.36552484 |
| 25 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.35531948 |
| 26 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.35321755 |
| 27 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.34132362 |
| 28 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.32847278 |
| 29 | ERA_21632823_ChIP-Seq_H3396_Human | 1.31283868 |
| 30 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.29668070 |
| 31 | TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 1.26693068 |
| 32 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.24578280 |
| 33 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.23857330 |
| 34 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.23497472 |
| 35 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.22670930 |
| 36 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.20723845 |
| 37 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.19674873 |
| 38 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.18220305 |
| 39 | SA1_27219007_Chip-Seq_Bcells_Human | 1.14302069 |
| 40 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.14016527 |
| 41 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.12252849 |
| 42 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.12116485 |
| 43 | NCOR_22424771_ChIP-Seq_293T_Human | 1.10174267 |
| 44 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.09962533 |
| 45 | TP63_22573176_ChIP-Seq_HFKS_Human | 1.09725503 |
| 46 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.09444978 |
| 47 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.08136850 |
| 48 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.07518811 |
| 49 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.07298545 |
| 50 | NANOG_20526341_ChIP-Seq_ESCs_Human | 1.07222273 |
| 51 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.05499683 |
| 52 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.03930616 |
| 53 | ETS1_21867929_ChIP-Seq_TH2_Mouse | 1.02813947 |
| 54 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.02662609 |
| 55 | CTCF_20526341_ChIP-Seq_ESCs_Human | 1.01840162 |
| 56 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.01193889 |
| 57 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.00731161 |
| 58 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.00301106 |
| 59 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.99669270 |
| 60 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.99478744 |
| 61 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 0.99343223 |
| 62 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.98346500 |
| 63 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.98200083 |
| 64 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.96450652 |
| 65 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.96020031 |
| 66 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.95964920 |
| 67 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.95207506 |
| 68 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.93662006 |
| 69 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.92661507 |
| 70 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.92661507 |
| 71 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.92352469 |
| 72 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.91621473 |
| 73 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 0.91027982 |
| 74 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.91016521 |
| 75 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.90628569 |
| 76 | TCF12/HEB_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.89863905 |
| 77 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 0.89327396 |
| 78 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.88914032 |
| 79 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 0.88800604 |
| 80 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.88691984 |
| 81 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.88611996 |
| 82 | OCT1_27270436_Chip-Seq_PROSTATE_Human | 0.86941435 |
| 83 | OCT4_20526341_ChIP-Seq_ESCs_Human | 0.86195645 |
| 84 | FLI1_21867929_ChIP-Seq_CD8_Mouse | 0.85177214 |
| 85 | ATF3_27146783_Chip-Seq_COLON_Human | 0.84927045 |
| 86 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 0.84763191 |
| 87 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.83619474 |
| 88 | FLI1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.83193142 |
| 89 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.82717181 |
| 90 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.82317248 |
| 91 | TCF4_23295773_ChIP-Seq_U87_Human | 0.81841598 |
| 92 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 0.80883059 |
| 93 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 0.80577494 |
| 94 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.80505233 |
| 95 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.80122115 |
| 96 | HOXB7_26014856_ChIP-Seq_BT474_Human | 0.80045935 |
| 97 | ELF5_23300383_ChIP-Seq_T47D_Human | 0.79673887 |
| 98 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.79207913 |
| 99 | MYC_19829295_ChIP-Seq_ESCs_Human | 0.79070885 |
| 100 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.78828347 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003195_calcinosis | 6.44284329 |
| 2 | MP0008995_early_reproductive_senescence | 5.74036171 |
| 3 | MP0009840_abnormal_foam_cell | 5.64295832 |
| 4 | MP0002876_abnormal_thyroid_physiology | 5.46554858 |
| 5 | MP0005360_urolithiasis | 4.96312458 |
| 6 | MP0003011_delayed_dark_adaptation | 4.35869131 |
| 7 | MP0004264_abnormal_extraembryonic_tissu | 3.16831278 |
| 8 | MP0005645_abnormal_hypothalamus_physiol | 2.96176600 |
| 9 | MP0003786_premature_aging | 2.03414514 |
| 10 | MP0002089_abnormal_postnatal_growth/wei | 1.85561526 |
| 11 | MP0005310_abnormal_salivary_gland | 1.82833134 |
| 12 | MP0010329_abnormal_lipoprotein_level | 1.82801543 |
| 13 | MP0005365_abnormal_bile_salt | 1.78857052 |
| 14 | MP0005332_abnormal_amino_acid | 1.76212704 |
| 15 | MP0004019_abnormal_vitamin_homeostasis | 1.76084841 |
| 16 | MP0003183_abnormal_peptide_metabolism | 1.76081127 |
| 17 | MP0003943_abnormal_hepatobiliary_system | 1.75966597 |
| 18 | MP0001873_stomach_inflammation | 1.74504045 |
| 19 | MP0002168_other_aberrant_phenotype | 1.73117625 |
| 20 | MP0005377_hearing/vestibular/ear_phenot | 1.72661611 |
| 21 | MP0003878_abnormal_ear_physiology | 1.72661611 |
| 22 | MP0004782_abnormal_surfactant_physiolog | 1.71684972 |
| 23 | MP0003045_fibrosis | 1.67994133 |
| 24 | MP0005410_abnormal_fertilization | 1.56518297 |
| 25 | MP0005647_abnormal_sex_gland | 1.56077413 |
| 26 | MP0005395_other_phenotype | 1.46553090 |
| 27 | MP0001666_abnormal_nutrient_absorption | 1.45839320 |
| 28 | MP0002009_preneoplasia | 1.45144392 |
| 29 | MP0008875_abnormal_xenobiotic_pharmacok | 1.41961845 |
| 30 | MP0000681_abnormal_thyroid_gland | 1.38043343 |
| 31 | MP0009643_abnormal_urine_homeostasis | 1.32813703 |
| 32 | MP0002163_abnormal_gland_morphology | 1.30852376 |
| 33 | MP0004133_heterotaxia | 1.29315961 |
| 34 | MP0005451_abnormal_body_composition | 1.22719755 |
| 35 | MP0003436_decreased_susceptibility_to | 1.22059401 |
| 36 | MP0003718_maternal_effect | 1.21712585 |
| 37 | MP0002277_abnormal_respiratory_mucosa | 1.20486315 |
| 38 | MP0003938_abnormal_ear_development | 1.19880005 |
| 39 | MP0002148_abnormal_hypersensitivity_rea | 1.18221646 |
| 40 | MP0003191_abnormal_cellular_cholesterol | 1.17803910 |
| 41 | MP0009785_altered_susceptibility_to | 1.15215771 |
| 42 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.14909896 |
| 43 | MP0002139_abnormal_hepatobiliary_system | 1.14268383 |
| 44 | MP0002332_abnormal_exercise_endurance | 1.14164129 |
| 45 | MP0000613_abnormal_salivary_gland | 1.08888851 |
| 46 | MP0001881_abnormal_mammary_gland | 1.07143209 |
| 47 | MP0002933_joint_inflammation | 1.05238932 |
| 48 | MP0005083_abnormal_biliary_tract | 1.03189148 |
| 49 | MP0002254_reproductive_system_inflammat | 1.00743936 |
| 50 | MP0005671_abnormal_response_to | 0.97771069 |
| 51 | MP0003656_abnormal_erythrocyte_physiolo | 0.97625007 |
| 52 | MP0001958_emphysema | 0.95588722 |
| 53 | MP0005085_abnormal_gallbladder_physiolo | 0.87129693 |
| 54 | MP0005646_abnormal_pituitary_gland | 0.84547077 |
| 55 | MP0000371_diluted_coat_color | 0.83857236 |
| 56 | MP0010307_abnormal_tumor_latency | 0.83395372 |
| 57 | MP0002136_abnormal_kidney_physiology | 0.82791897 |
| 58 | MP0004742_abnormal_vestibular_system | 0.81613955 |
| 59 | MP0003698_abnormal_male_reproductive | 0.81580896 |
| 60 | MP0005058_abnormal_lysosome_morphology | 0.78320519 |
| 61 | MP0002118_abnormal_lipid_homeostasis | 0.77907703 |
| 62 | MP0001905_abnormal_dopamine_level | 0.77594834 |
| 63 | MP0004270_analgesia | 0.77391114 |
| 64 | MP0003646_muscle_fatigue | 0.76344590 |
| 65 | MP0000249_abnormal_blood_vessel | 0.76322507 |
| 66 | MP0005636_abnormal_mineral_homeostasis | 0.75983374 |
| 67 | MP0002229_neurodegeneration | 0.74879955 |
| 68 | MP0003690_abnormal_glial_cell | 0.74281536 |
| 69 | MP0004947_skin_inflammation | 0.73897511 |
| 70 | MP0001765_abnormal_ion_homeostasis | 0.73673736 |
| 71 | MP0000003_abnormal_adipose_tissue | 0.72895060 |
| 72 | MP0005535_abnormal_body_temperature | 0.72092842 |
| 73 | MP0000639_abnormal_adrenal_gland | 0.67888927 |
| 74 | MP0000026_abnormal_inner_ear | 0.67389855 |
| 75 | MP0000685_abnormal_immune_system | 0.66235657 |
| 76 | MP0010155_abnormal_intestine_physiology | 0.65910169 |
| 77 | MP0001664_abnormal_digestion | 0.65360859 |
| 78 | MP0005379_endocrine/exocrine_gland_phen | 0.65134695 |
| 79 | MP0004043_abnormal_pH_regulation | 0.64714461 |
| 80 | MP0001501_abnormal_sleep_pattern | 0.62961501 |
| 81 | MP0008877_abnormal_DNA_methylation | 0.61914533 |
| 82 | MP0008872_abnormal_physiological_respon | 0.61220248 |
| 83 | MP0000427_abnormal_hair_cycle | 0.59738872 |
| 84 | MP0001879_abnormal_lymphatic_vessel | 0.59242360 |
| 85 | MP0008569_lethality_at_weaning | 0.57621277 |
| 86 | MP0009642_abnormal_blood_homeostasis | 0.57284943 |
| 87 | MP0002098_abnormal_vibrissa_morphology | 0.55115213 |
| 88 | MP0001929_abnormal_gametogenesis | 0.52803793 |
| 89 | MP0001119_abnormal_female_reproductive | 0.52246062 |
| 90 | MP0000049_abnormal_middle_ear | 0.51999912 |
| 91 | MP0004233_abnormal_muscle_weight | 0.51454057 |
| 92 | MP0004134_abnormal_chest_morphology | 0.51230134 |
| 93 | MP0002166_altered_tumor_susceptibility | 0.50526189 |
| 94 | MP0005334_abnormal_fat_pad | 0.50355079 |
| 95 | MP0004858_abnormal_nervous_system | 0.49871471 |
| 96 | MP0000013_abnormal_adipose_tissue | 0.49384731 |
| 97 | MP0008469_abnormal_protein_level | 0.49235801 |
| 98 | MP0002210_abnormal_sex_determination | 0.48473986 |
| 99 | MP0002723_abnormal_immune_serum | 0.47043902 |
| 100 | MP0005025_abnormal_response_to | 0.46686622 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of homocysteine metabolism (HP:0010919) | 6.30290406 |
| 2 | Homocystinuria (HP:0002156) | 6.30290406 |
| 3 | Abnormality of the aortic arch (HP:0012303) | 5.15418165 |
| 4 | Hyperlipoproteinemia (HP:0010980) | 5.12406431 |
| 5 | Nausea (HP:0002018) | 4.40594800 |
| 6 | Malnutrition (HP:0004395) | 4.28534099 |
| 7 | Hypobetalipoproteinemia (HP:0003563) | 4.27246194 |
| 8 | Pendular nystagmus (HP:0012043) | 3.96948501 |
| 9 | Abnormality of macular pigmentation (HP:0008002) | 3.93794658 |
| 10 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 3.89869248 |
| 11 | Severe visual impairment (HP:0001141) | 3.70224754 |
| 12 | Abnormality of vitamin B metabolism (HP:0004340) | 3.58417398 |
| 13 | Absent/shortened dynein arms (HP:0200106) | 3.50470847 |
| 14 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 3.50470847 |
| 15 | Severe Myopia (HP:0011003) | 3.48422427 |
| 16 | Abnormality of the nasal septum (HP:0000419) | 3.46580290 |
| 17 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.43869897 |
| 18 | Pustule (HP:0200039) | 3.43675105 |
| 19 | Hypolipoproteinemia (HP:0010981) | 3.40047232 |
| 20 | J-shaped sella turcica (HP:0002680) | 3.31080223 |
| 21 | Thyroid-stimulating hormone excess (HP:0002925) | 3.29017172 |
| 22 | Megaloblastic anemia (HP:0001889) | 3.26917875 |
| 23 | Abnormality of methionine metabolism (HP:0010901) | 3.25919205 |
| 24 | Hydroxyprolinuria (HP:0003080) | 3.10122114 |
| 25 | Abnormality of proline metabolism (HP:0010907) | 3.10122114 |
| 26 | Renal cell carcinoma (HP:0005584) | 2.91342610 |
| 27 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.91047426 |
| 28 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.89009632 |
| 29 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.87538429 |
| 30 | Peripheral hypomyelination (HP:0007182) | 2.75813870 |
| 31 | Abnormality of vitamin metabolism (HP:0100508) | 2.73523160 |
| 32 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.67674101 |
| 33 | Midline defect of the nose (HP:0004122) | 2.66804023 |
| 34 | Visual hallucinations (HP:0002367) | 2.59157107 |
| 35 | Gonadotropin excess (HP:0000837) | 2.54362711 |
| 36 | Ulnar claw (HP:0001178) | 2.44154221 |
| 37 | Hypoalphalipoproteinemia (HP:0003233) | 2.41982961 |
| 38 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 2.40510743 |
| 39 | Dysostosis multiplex (HP:0000943) | 2.35276068 |
| 40 | Azoospermia (HP:0000027) | 2.34465482 |
| 41 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.31470164 |
| 42 | Gonadal dysgenesis (HP:0000133) | 2.31324032 |
| 43 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.29946636 |
| 44 | Pheochromocytoma (HP:0002666) | 2.29580126 |
| 45 | Goiter (HP:0000853) | 2.29232141 |
| 46 | Infertility (HP:0000789) | 2.28461498 |
| 47 | Acne (HP:0001061) | 2.23040052 |
| 48 | Broad alveolar ridges (HP:0000187) | 2.21901436 |
| 49 | Abnormality of the distal phalanges of the toes (HP:0010182) | 2.21479109 |
| 50 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.18699627 |
| 51 | Abnormality of the ileum (HP:0001549) | 2.17724945 |
| 52 | Chronic diarrhea (HP:0002028) | 2.14768651 |
| 53 | Steatorrhea (HP:0002570) | 2.14259962 |
| 54 | Neonatal respiratory distress (HP:0002643) | 2.14080566 |
| 55 | Aplasia/Hypoplasia of the clavicles (HP:0006710) | 2.13696903 |
| 56 | Loss of speech (HP:0002371) | 2.10718465 |
| 57 | Abnormality of glycolipid metabolism (HP:0010969) | 2.10117735 |
| 58 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.10117735 |
| 59 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.10117735 |
| 60 | Alveolar cell carcinoma (HP:0006519) | 2.10013041 |
| 61 | Abnormal respiratory epithelium morphology (HP:0012253) | 2.09027112 |
| 62 | Abnormal respiratory motile cilium morphology (HP:0005938) | 2.09027112 |
| 63 | Decreased central vision (HP:0007663) | 2.08125749 |
| 64 | Vacuolated lymphocytes (HP:0001922) | 2.04848118 |
| 65 | Meckel diverticulum (HP:0002245) | 2.03797991 |
| 66 | Flat acetabular roof (HP:0003180) | 2.03246930 |
| 67 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.03022594 |
| 68 | Exocrine pancreatic insufficiency (HP:0001738) | 2.02982491 |
| 69 | Aplasia/Hypoplasia of the abdominal wall musculature (HP:0010318) | 2.00817546 |
| 70 | Fat malabsorption (HP:0002630) | 2.00220409 |
| 71 | Increased cerebral lipofuscin (HP:0011813) | 1.97934276 |
| 72 | Clubbing of toes (HP:0100760) | 1.97216297 |
| 73 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.95768572 |
| 74 | Episodic fever (HP:0001954) | 1.95498288 |
| 75 | Central scotoma (HP:0000603) | 1.91608840 |
| 76 | Axonal loss (HP:0003447) | 1.90618989 |
| 77 | Tetany (HP:0001281) | 1.88982392 |
| 78 | Abnormality of the fovea (HP:0000493) | 1.87745347 |
| 79 | Absent hand (HP:0004050) | 1.87536741 |
| 80 | Increased serum ferritin (HP:0003281) | 1.85888482 |
| 81 | Carpal bone hypoplasia (HP:0001498) | 1.85832269 |
| 82 | True hermaphroditism (HP:0010459) | 1.85425068 |
| 83 | Abnormality of lateral ventricle (HP:0030047) | 1.85154510 |
| 84 | Split foot (HP:0001839) | 1.85056905 |
| 85 | Hypomagnesemia (HP:0002917) | 1.83899587 |
| 86 | Abnormality of the preputium (HP:0100587) | 1.82192074 |
| 87 | Abnormality of the lumbar spine (HP:0100712) | 1.80261497 |
| 88 | Congenital sensorineural hearing impairment (HP:0008527) | 1.77476070 |
| 89 | Hyperglycinuria (HP:0003108) | 1.74615902 |
| 90 | Mucopolysacchariduria (HP:0008155) | 1.72207075 |
| 91 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.72207075 |
| 92 | Meningioma (HP:0002858) | 1.71225726 |
| 93 | Abnormality of the carotid arteries (HP:0005344) | 1.70743839 |
| 94 | Natal tooth (HP:0000695) | 1.69999860 |
| 95 | Nuclear cataract (HP:0100018) | 1.69210234 |
| 96 | Neoplasm of the tracheobronchial system (HP:0100552) | 1.68804838 |
| 97 | Diastasis recti (HP:0001540) | 1.68721212 |
| 98 | Neuroendocrine neoplasm (HP:0100634) | 1.68640515 |
| 99 | Decreased circulating renin level (HP:0003351) | 1.67738310 |
| 100 | Nonprogressive disorder (HP:0003680) | 1.67460154 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PINK1 | 4.65033645 |
| 2 | NTRK3 | 4.00262421 |
| 3 | MST1R | 3.74493899 |
| 4 | PIK3CG | 3.70765092 |
| 5 | MUSK | 3.61214735 |
| 6 | EPHA3 | 3.54186762 |
| 7 | TSSK6 | 3.29969870 |
| 8 | TYK2 | 2.83120356 |
| 9 | MAP3K6 | 2.73947220 |
| 10 | ADRBK2 | 2.45807097 |
| 11 | EPHB2 | 2.39242171 |
| 12 | EPHA4 | 2.39095167 |
| 13 | WNK3 | 2.01694427 |
| 14 | PRKG2 | 1.80465455 |
| 15 | BCR | 1.80088617 |
| 16 | TXK | 1.69940143 |
| 17 | NME1 | 1.63236628 |
| 18 | MAP2K6 | 1.59229102 |
| 19 | ZAP70 | 1.57222082 |
| 20 | JAK1 | 1.55348320 |
| 21 | FGFR4 | 1.54843472 |
| 22 | TLK1 | 1.41628374 |
| 23 | CSF1R | 1.39772550 |
| 24 | TBK1 | 1.38318343 |
| 25 | ACVR1B | 1.38285471 |
| 26 | ZAK | 1.35778281 |
| 27 | MAPKAPK3 | 1.34434845 |
| 28 | EPHA2 | 1.32851806 |
| 29 | DAPK2 | 1.31211442 |
| 30 | MAP3K13 | 1.29148605 |
| 31 | TEC | 1.20942536 |
| 32 | RIPK1 | 1.18578458 |
| 33 | SIK1 | 1.17180144 |
| 34 | ICK | 1.16340002 |
| 35 | CDK12 | 1.11829889 |
| 36 | RPS6KB2 | 1.11287317 |
| 37 | MINK1 | 1.10509975 |
| 38 | INSRR | 1.09830992 |
| 39 | FES | 1.06520531 |
| 40 | TESK2 | 1.05621360 |
| 41 | MAP2K3 | 1.05087091 |
| 42 | TYRO3 | 0.99306920 |
| 43 | SIK2 | 0.94803609 |
| 44 | ABL2 | 0.90178739 |
| 45 | MAP3K5 | 0.88272919 |
| 46 | IRAK1 | 0.88141512 |
| 47 | DYRK1B | 0.85445993 |
| 48 | OXSR1 | 0.84713778 |
| 49 | MET | 0.83384674 |
| 50 | EEF2K | 0.81521121 |
| 51 | TAOK3 | 0.77070277 |
| 52 | MAP4K1 | 0.69893216 |
| 53 | MATK | 0.68881737 |
| 54 | MAPK11 | 0.66281917 |
| 55 | STK24 | 0.62806129 |
| 56 | TAF1 | 0.62692018 |
| 57 | DDR2 | 0.61921987 |
| 58 | IKBKB | 0.61895259 |
| 59 | IRAK3 | 0.61617837 |
| 60 | STK39 | 0.61609334 |
| 61 | MAP3K14 | 0.60816900 |
| 62 | LMTK2 | 0.60795187 |
| 63 | CHUK | 0.60413733 |
| 64 | LCK | 0.59836096 |
| 65 | MAP2K2 | 0.58579706 |
| 66 | BUB1 | 0.56442121 |
| 67 | ERN1 | 0.56155580 |
| 68 | IGF1R | 0.54837863 |
| 69 | MAP2K4 | 0.54236093 |
| 70 | PDPK1 | 0.52895410 |
| 71 | PTK6 | 0.51493672 |
| 72 | BRD4 | 0.50857145 |
| 73 | MAPK15 | 0.48256009 |
| 74 | STK11 | 0.45770090 |
| 75 | CSK | 0.43981794 |
| 76 | GRK1 | 0.43813230 |
| 77 | CDC42BPA | 0.43177964 |
| 78 | MAP3K7 | 0.43008551 |
| 79 | PDK1 | 0.42987663 |
| 80 | PRPF4B | 0.42463469 |
| 81 | ABL1 | 0.40280527 |
| 82 | CDK9 | 0.39708447 |
| 83 | JAK3 | 0.38788970 |
| 84 | PDGFRB | 0.37166217 |
| 85 | SRC | 0.34454366 |
| 86 | FGFR3 | 0.33417905 |
| 87 | WNK4 | 0.31842324 |
| 88 | WNK1 | 0.31237763 |
| 89 | LYN | 0.31142314 |
| 90 | MAP3K12 | 0.29973776 |
| 91 | TRPM7 | 0.28439854 |
| 92 | PLK4 | 0.27457987 |
| 93 | PRKCZ | 0.24844124 |
| 94 | MAPK8 | 0.24716565 |
| 95 | HCK | 0.24219787 |
| 96 | FYN | 0.24034210 |
| 97 | MAPK10 | 0.23309480 |
| 98 | GRK6 | 0.23256854 |
| 99 | RPS6KA2 | 0.23222829 |
| 100 | CAMKK2 | 0.19101481 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 8.05213295 |
| 2 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 5.57204882 |
| 3 | Selenocompound metabolism_Homo sapiens_hsa00450 | 5.33050790 |
| 4 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 2.97926885 |
| 5 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 2.76204942 |
| 6 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.61769488 |
| 7 | One carbon pool by folate_Homo sapiens_hsa00670 | 2.37711304 |
| 8 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 2.31799652 |
| 9 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.98497484 |
| 10 | Mineral absorption_Homo sapiens_hsa04978 | 1.68409121 |
| 11 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 1.66271673 |
| 12 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.65553130 |
| 13 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.50617225 |
| 14 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 1.50347434 |
| 15 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.41889977 |
| 16 | Galactose metabolism_Homo sapiens_hsa00052 | 1.38767430 |
| 17 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.31471565 |
| 18 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.22108230 |
| 19 | Retinol metabolism_Homo sapiens_hsa00830 | 1.09040325 |
| 20 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.06690844 |
| 21 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.05542984 |
| 22 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 1.01674613 |
| 23 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.00726980 |
| 24 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.94490861 |
| 25 | Cocaine addiction_Homo sapiens_hsa05030 | 0.92384770 |
| 26 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.91481818 |
| 27 | Other glycan degradation_Homo sapiens_hsa00511 | 0.84607277 |
| 28 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.84050225 |
| 29 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.83484320 |
| 30 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.82612861 |
| 31 | Lysosome_Homo sapiens_hsa04142 | 0.80770602 |
| 32 | Salivary secretion_Homo sapiens_hsa04970 | 0.79849275 |
| 33 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.79822623 |
| 34 | ABC transporters_Homo sapiens_hsa02010 | 0.79049269 |
| 35 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.77356878 |
| 36 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.74830170 |
| 37 | Sulfur relay system_Homo sapiens_hsa04122 | 0.73678068 |
| 38 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.71646273 |
| 39 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.71567612 |
| 40 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.69397547 |
| 41 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.68181183 |
| 42 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.66989408 |
| 43 | Allograft rejection_Homo sapiens_hsa05330 | 0.64234193 |
| 44 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.64155375 |
| 45 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.63403405 |
| 46 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.61881992 |
| 47 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.61452725 |
| 48 | Hepatitis C_Homo sapiens_hsa05160 | 0.61310219 |
| 49 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.60248102 |
| 50 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.60015824 |
| 51 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.58440810 |
| 52 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.57792970 |
| 53 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.57364836 |
| 54 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.55110482 |
| 55 | Influenza A_Homo sapiens_hsa05164 | 0.52469365 |
| 56 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.51911070 |
| 57 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.51874106 |
| 58 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.51383885 |
| 59 | Bile secretion_Homo sapiens_hsa04976 | 0.50465982 |
| 60 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.48580974 |
| 61 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.48245759 |
| 62 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.46736350 |
| 63 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.44012409 |
| 64 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.42955116 |
| 65 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.41742242 |
| 66 | Tight junction_Homo sapiens_hsa04530 | 0.41311858 |
| 67 | Pertussis_Homo sapiens_hsa05133 | 0.39811495 |
| 68 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.38147745 |
| 69 | Histidine metabolism_Homo sapiens_hsa00340 | 0.38079559 |
| 70 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.37236997 |
| 71 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.36889460 |
| 72 | Insulin resistance_Homo sapiens_hsa04931 | 0.36157365 |
| 73 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.35986767 |
| 74 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.34544948 |
| 75 | Nicotine addiction_Homo sapiens_hsa05033 | 0.33549948 |
| 76 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.33477757 |
| 77 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.33224432 |
| 78 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.32792765 |
| 79 | Morphine addiction_Homo sapiens_hsa05032 | 0.31699691 |
| 80 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.30605707 |
| 81 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.28063104 |
| 82 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.27616017 |
| 83 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.27558895 |
| 84 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.27394640 |
| 85 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.26410628 |
| 86 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.26275618 |
| 87 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.24056775 |
| 88 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.24055388 |
| 89 | Malaria_Homo sapiens_hsa05144 | 0.22323131 |
| 90 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.21388249 |
| 91 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.19571478 |
| 92 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.18606671 |
| 93 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.18212054 |
| 94 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.18054815 |
| 95 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.16528464 |
| 96 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.16438140 |
| 97 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.15736201 |
| 98 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.15598766 |
| 99 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.15249649 |
| 100 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.14900991 |

